FAQ
Log In
Thursday 23rd February 2017
News
 › 
 › 

Heads of research removed from AstraZeneca

16th January 2013

AstraZeneca’s new chief executive Pascal Soriot has made changes to the management structure of Britain’s second biggest pharmaceutical company.

Soriot, who took over in October, has removed the heads of research and commercial operations – Martin Mackay and Tony Zook - in a management revamp designed to speed decision-making, with both men leaving the company at the end of January. They will be replaced by three senior research and development roles, while on the commercial side of the company three positions will represent different regions.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Heads of research removed from AstraZeneca
Author: Mark Nicholls
Article Id: 23526
Date Added: 16th Jan 2013

Sources

Yahoo News

Recent Related Articles

Brain scans to spot teenage drug problems

Malaria drugs fail

Cancer drug prices rising

Drug could encourage teeth to repair themselves

Viruses can evolve according to research

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2017